Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

New Feature: All Finviz Members Now Get Real-Time Earnings Data

Tectonic Therapeutic

Contributing Author

Recent Articles by Tectonic Therapeutic

Sep-29	Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT) TECX GlobeNewswire
Sep-03	Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference TECX GlobeNewswire
Aug-06	Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights TECX GlobeNewswire
Jun-10	Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients TECX GlobeNewswire
May-07	Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights TECX -7.41% TECX +7.93% GlobeNewswire
Apr-23	Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors TECX GlobeNewswire
Mar-02	Tectonic Therapeutic to Participate in March Investor Conferences TECX GlobeNewswire
Feb-26	Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights TECX GlobeNewswire
Feb-23	Tectonic Therapeutic Appoints Francois Nader, M.D., as Chair and Independent Director of the Board TECX GlobeNewswire
Feb-11	Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026 TECX GlobeNewswire
Dec-01	Tectonic Therapeutic to Participate in December Investor Conferences TECX GlobeNewswire
Nov-06	Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights TECX +15.51% GlobeNewswire
Oct-29	Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF TECX TECX -5.48% GlobeNewswire
Aug-28	Tectonic Therapeutic to Participate in September Investor Conferences TECX GlobeNewswire
Aug-07	Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights TECX -5.35% GlobeNewswire
Jun-30	Tectonic Therapeutic Joins Russell 3000 Index TECX GlobeNewswire
May-17	Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025 TECX GlobeNewswire
May-08	Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights TECX +10.81% TECX -5.99% GlobeNewswire
May-07	Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference TECX GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)